Gemseki Ventures L.P. Investment in Curreio


Gemseki Ventures L.P. is pleased to announce our investment in Curreio.

Curreio is a Tokyo-based biotech startup that aims to create innovative drugs with the world's most advanced technology in structural analysis of biomolecules using cryo-electron microscopy.

Gemseki will stand with Curreio to take on the challenges and continue to support drug developments that contribute to humanity and society.


Link: Press release by Curreio